Yuan Yuan

Targeting Chemotherapy-Induced Breast Cancer Stemness

National Cancer Institute · R01

PI · $2.3M · University of California, San Diego

Peripheral Blood Biomarkers of Molecular Aging Predicting Chemotherapy Induced Toxicity and Functional Decline in Women 60 and Older with Breast Cancer

National Institute on Aging · R03

Contact PI · $255K · Beckman Research Institute/City of Hope

Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer

Principal investigator · Not yet recruiting · Phase 2

Yuan Yuan

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Principal investigator · Recruiting · Phase 2

Cedars-Sinai Medical Center

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Principal investigator · Recruiting · Phase 1, Phase 2

Yuan Yuan

Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer

Principal investigator · Withdrawn

City of Hope Medical Center